Licensed cultivator and processor of pharmaceutical-grade cannabis.
Dedicated to improving patients’ quality of life across the globe. Based in Jersey, Northern Leaf is accredited to the highest level cultivation and post cultivation pharmaceutical standards – GACP and EU-GMP respectively.
How we operate
Northern Leaf employs the highest standards of cultivation and operational best practice
Led by a diverse team of highly experienced sector and functional experts and operating to strict pharmaceutical regulation, Northern Leaf is positioned to become a leader in Europe in the cultivation and supply of high quality and consistent cannabis-based medicines.
The significant investment into our facility gives us the control we need over our growing and processing conditions – a key element in enabling consistency, batch after batch.
Northern Leaf operates from a 100,000 sq.ft facility that, at capacity, can produce 6-8 tonnes of dried flower per annum.
Our processes are designed to produce the quality and consistency that is required by prescribing physicians and patients globally. Our end product is an Active Pharmaceutical Ingredient (“API”), governed by EU-GMP Part II which is used to manufacture finished medicines.
Led by Head of Cultivation, Asaf Shaked, we develop and test new strains, enabling us to identify the highest-grade products to bring to market.
Based in Jersey, Northern Leaf benefits from significant advantages including conducive climate, experienced labour, a supportive regulatory backdrop and highly competitive energy costs.
Northern Leaf is accredited to the highest standards. We are EU GMP and GACP accredited and have been awarded a commercial license by the UK Home Office, permitting for the cultivation, production, possession, and supply of high-THC cannabis.
Northern Leaf’s accreditations enable it to sell across the globe to regulated cannabis markets. The Company is pursuing commercial opportunities within the UK, EU, and international markets.